Cellectis SA (CLLS)
3.08
+0.04
(+1.32%)
USD |
NASDAQ |
May 15, 14:25
Cellectis Enterprise Value: 48.53M for May 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 14, 2024 | 48.53M |
May 13, 2024 | 43.49M |
May 10, 2024 | 49.97M |
May 09, 2024 | 62.92M |
May 08, 2024 | 52.85M |
May 07, 2024 | 52.85M |
May 06, 2024 | 70.84M |
May 03, 2024 | 44.93M |
May 02, 2024 | 44.93M |
May 01, 2024 | 12.27M |
April 30, 2024 | 13.99M |
April 29, 2024 | 13.99M |
April 26, 2024 | 10.08M |
April 25, 2024 | 8.955M |
April 24, 2024 | 9.675M |
April 23, 2024 | 18.29M |
April 22, 2024 | 19.75M |
April 19, 2024 | 13.27M |
April 18, 2024 | 7.516M |
April 17, 2024 | 6.797M |
April 16, 2024 | 8.955M |
April 15, 2024 | 17.59M |
April 12, 2024 | 23.35M |
April 11, 2024 | 31.26M |
April 10, 2024 | 30.54M |
Date | Value |
---|---|
April 09, 2024 | 27.66M |
April 08, 2024 | 23.35M |
April 05, 2024 | 22.63M |
April 04, 2024 | 27.66M |
April 03, 2024 | 30.54M |
April 02, 2024 | 20.47M |
April 01, 2024 | 12.55M |
March 28, 2024 | 19.93M |
March 27, 2024 | 21.37M |
March 26, 2024 | 14.19M |
March 25, 2024 | 14.91M |
March 22, 2024 | 9.169M |
March 21, 2024 | 11.32M |
March 20, 2024 | 5.581M |
March 19, 2024 | 2.711M |
March 18, 2024 | 8.452M |
March 15, 2024 | 12.04M |
March 14, 2024 | 11.32M |
March 13, 2024 | 13.47M |
March 12, 2024 | 17.78M |
March 11, 2024 | 4.146M |
March 08, 2024 | 15.63M |
March 07, 2024 | 9.886M |
March 06, 2024 | 10.60M |
March 05, 2024 | 7.734M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.54M
Minimum
Jun 16 2022
1.203B
Maximum
Jan 19 2021
253.04M
Average
170.73M
Median
Dec 06 2023
Enterprise Value Benchmarks
DBV Technologies SA | 12.08M |
Genfit SA | 169.07M |
Biophytis SA | 2.214M |
Edap TMS SA | 214.24M |
Adaptimmune Therapeutics PLC | 136.91M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -42.86M |
Revenue (Quarterly) | 0.283M |
Total Expenses (Quarterly) | 29.86M |
EPS Diluted (Quarterly) | -0.70 |
Gross Profit Margin (Quarterly) | 40.99% |
Profit Margin (Quarterly) | -15.15K% |
Earnings Yield | -57.79% |
Normalized Earnings Yield | -58.31 |